Valproic Acid and Autism: Unlocking the Link Between Epilepsy Drugs and Brain Development
Source Publication
Primary AuthorsRodrigues, Silva, Andreotti et al.

How Valproic Acid and Autism are Linked in the Lab
To understand this connection, researchers injected pregnant mice with valproic acid (VPA). They then waited for the male offspring to grow up. If the drug changed brain development, then the mice should act differently from those born to untreated mothers.
The results were stark. The mice exposed to VPA displayed high levels of anxiety. They avoided other mice. They struggled to learn from negative experiences. These behaviours mirror the social and sensory challenges often seen in humans on the autism spectrum.
A Surprise in the Frontal Cortex
The team didn't just watch the mice; they looked inside their brains. They measured specific proteins in the frontal cortex, the area responsible for complex thinking and personality.
They found two major changes:
- PSD-95: A marker for synaptic connection. Levels were unusually high, suggesting the brain was 'over-connected' or too excitable.
- Klotho: A protein usually associated with anti-ageing.
This is where it gets interesting. The study measured a significant spike in Klotho levels in the frontal cortex, though not in the hippocampus or cerebellum.
What Does This Mean?
The presence of extra Klotho is a puzzle. It suggests the brain might be trying to protect itself from the initial damage caused by the drug. Alternatively, the excess protein could be contributing to the problem. If Klotho is acting as a shield, it could become a target for future treatments. However, because this was an animal study, we cannot yet say for certain if the same chemical spikes happen in humans. It simply points us toward where to look next.